BioLineRx (BLRX) Other Working Capital Changes (2019 - 2025)
BioLineRx's (BLRX) quarterly Other Working Capital Changes came in at -$113000.0 in Q4 2025, up 13.74% year-on-year from -$99349.0 in Q4 2024, and up 17.52% quarter-over-quarter from -$137000.0 in Q3 2025.
BioLineRx (BLRX) Other Working Capital Changes (2019 - 2025) Analysis & Trends
BioLineRx's Other Working Capital Changes history runs 7 years deep, the most recent figure standing at -$113000.0 for Q4 2025.
- On a quarterly basis, Other Working Capital Changes rose 13.74% year-over-year to -$113000.0 in Q4 2025; TTM through Dec 2025 was -$512000.0, a 0.2% change from a year earlier, with the FY2025 full-year figure at -$512000.0, changed 0.2% from the prior year.
- Other Working Capital Changes improved to -$113000.0 in Q4 2025 per BLRX's latest filing, from -$137000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $1.2 million in Q1 2025 and bottomed at -$976000.0 in Q1 2021.
- The 5-year median for Other Working Capital Changes is -$101500.0 (2022), against an average of -$15900.0.
- Across the five-year window, Other Working Capital Changes soared 45.21% in 2022 and plunged 268.42% in 2023, its largest moves.
- Year by year, Other Working Capital Changes stood at -$51000.0 in 2021, then plunged by 84.31% to -$94000.0 in 2022, then fell by 29.79% to -$122000.0 in 2023, then retreated by 7.38% to -$131000.0 in 2024, then climbed by 13.74% to -$113000.0 in 2025.
- Per Business Quant, the three latest BLRX Other Working Capital Changes figures stand at -$113000.0 (Q4 2025), -$137000.0 (Q3 2025), and -$135000.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | BioLineRx | 7.05 Bn | 7.06 Bn | 154,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -113,000.00 |
| Dec 31, 2025 | -113,000.00 |
| Dec 31, 2025 | -113,000.00 |
| Sep 30, 2025 | -137,000.00 |
| Sep 30, 2025 | -137,000.00 |
| Sep 30, 2025 | -137,000.00 |
| Jun 30, 2025 | -135,000.00 |
| Jun 30, 2025 | -135,000.00 |
| Jun 30, 2025 | -135,000.00 |
| Mar 31, 2025 | -127,000.00 |
| Mar 31, 2025 | -127,000.00 |
| Mar 31, 2025 | -127,000.00 |
| Dec 31, 2024 | -131,000.00 |
| Dec 31, 2024 | -131,000.00 |
| Dec 31, 2024 | -131,000.00 |
| Sep 30, 2024 | -124,000.00 |
| Sep 30, 2024 | -124,000.00 |
| Sep 30, 2024 | -124,000.00 |
| Jun 30, 2024 | -127,000.00 |
| Jun 30, 2024 | -127,000.00 |